NUSADAILY.COM – JAKARTA – The number of COVID-19 patients in United States hospitals on Wednesday (21/10) reached 40,000 for the first time since August, according to a Reuters tally.
The number of hospitalized patients due to corona has increased sharply. When the state declared a spike in infections in a number of states in the Midwest region. Hospitals have seen a 36 percent increase in coronavirus patients over the past four weeks and hospitals in the Midwest are daily registering new highs.
So far in October, 16 states have reported the highest daily numbers of COVID-19. Regarding patients who have been hospitalized since the pandemic began to emerge.
Among the territories with such reports are states in the Midwest, namely Iowa, Kansas, Missouri, Nebraska, North Dakota, South Dakota, and Wisconsin.
Hospitalizations of patients stricken with the coronavirus have set the highest records in every region, except in the Northeast region. Hospitalization is a closely watched metric because it cannot be relied on by many tests performed.
New Covid-19 Cases Increase 45 Percent
In addition to hospitalizations reaching 40,264 people as of Wednesday, new cases of COVID-19 on an average of seven days have increased 45 percent in the past four weeks. The number of new cases also points to levels last seen during the height of the summer, according to a Reuters analysis.
On Friday (16/10), the US recorded 69,478 new cases. It is the highest one-day total since July 24 and the fifth highest one-day total since the pandemic emerged.
Wisconsin Governor Tony Evers announced. That a field hospital on the outskirts of Milwaukee has received its first COVID-19 patient since opening last week.
“My friends, please stay home,” said Evers. “Help us protect our communities from this highly contagious virus and don’t overwhelm our hospitals.”
In New Mexico, the governor on Monday warned that the state’s health care resources may be insufficient if coronavirus cases continue to increase at the current pace.
The US National Health Agency (NIH) has begun its final stages of trials. To evaluate whether immune modulation therapies from three drug companies could help reduce the need for ventilators. For COVID-19 patients and shorten the hospital stay.
The research will involve up to 2,100 hospitalized adults with moderate to severe symptoms of COVID-19 in the United States and Latin America. (int1)